[144] Braze, Inc. SEC Filing
Braze, Inc. (BRZE) Form 144 notifies the market that 4,174 common shares with an aggregate market value of $136,783.23 are proposed to be sold, with an approximate sale date of 09/18/2025. The broker is Morgan Stanley Smith Barney LLC. The shares were acquired on 05/15/2025 as 1,710 performance shares and 2,464 restricted stock, with payment noted as not applicable. The filing also discloses a prior sale by Pankaj Malik of 2,344 shares on 08/19/2025 for $60,806.06. The filer certifies no undisclosed material adverse information.
- Transparent disclosure of planned sale: 4,174 shares and aggregate market value $136,783.23
- Broker identified as Morgan Stanley Smith Barney LLC, providing a clear execution channel
- Acquisition details provided (dates and nature: performance shares and restricted stock)
- Recent insider selling activity: 2,344 shares sold on 08/19/2025 for $60,806.06 may be viewed negatively by some investors
Insights
TL;DR Routine insider sale notice: 4,174 shares listed for sale with recent prior sale of 2,344 shares.
The Form 144 is a standard regulatory notice that an affiliate plans to sell 4,174 common shares (market value $136,783.23) via Morgan Stanley Smith Barney LLC with an approximate sale date of 09/18/2025. The securities were granted on 05/15/2025 as performance shares and restricted stock, indicating these are recent compensatory issuances being monetized. The prior sale by the same person on 08/19/2025 for $60,806.06 is disclosed, which is relevant for tracking insider disposition activity but does not by itself indicate a material change to company fundamentals.
TL;DR Filing appears complete for Rule 144 notice; shows recent grants and subsequent disposition activity.
The notice includes required details: broker, share counts, acquisition dates, and past 3-month sales (2,344 shares on 08/19/2025). Acquisition types are listed as performance shares and restricted stock, and payment is recorded as not applicable, consistent with equity grants. The signer affirms no undisclosed material adverse information. No governance or regulatory exceptions are stated in the filing.